Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2015 by University of Cincinnati
Sponsor:
Collaborator:
The Cleveland Clinic
Information provided by (Responsible Party):
Robert P Baughman, University of Cincinnati
ClinicalTrials.gov Identifier:
NCT01467791
First received: November 4, 2011
Last updated: January 26, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2018
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)